Cited by 1,275Liver Disease Diagnosis and TreatmentUltrasound Imaging and ElastographyUltrasound in Clinical Applications

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Open access

Karlas, Thomas, Petroff, David, Sasso, Magali, Fan, Jian-Gao, Mi, Yu-Qiang, de Lédinghen, Victor, Kumar, Manoj, Lupsor-Platon, Monica, Han, Kwang-Hyub, Cardoso, Ana C., Ferraioli, Giovanna, Chan, Wah-Kheong, Wong, Vincent Wai-Sun, Myers, Robert P., Chayama, Kazuaki, Friedrich-Rust, Mireen, Beaugrand, Michel, Shen, Feng, Hiriart, Jean-Baptiste, Sarin, Shiv K., Badea, Radu, Jung, Kyu Sik, Marcellin, Patrick, Filice, Carlo, Mahadeva, Sanjiv, Wong, Grace Lai-Hung, Crotty, Pam, Masaki, Keiichi, Bojunga, Joerg, Bedossa, Pierre, Keim, Volker, Wiegand, Johannes·2017·Journal of Hepatology

DOI 10.1016/j.jhep.2016.12.022

Open this paper in CoChat — free account

Abstract

Background & aims The prevalence of fatty liver underscores the need for non-invasive characterization of steatosis, such as the ultrasound based controlled attenuation parameter (CAP). Despite good diagnostic accuracy, clinical use of CAP is limited due to uncertainty regarding optimal cut-offs and the influence of covariates. We therefore conducted an individual patient data meta-analysis.Methods A review of the literature identified studies containing histology verified CAP data (M probe, vibration controlled transient elastography with FibroScan®) for grading of steatosis (S0-S3). Receiver operating characteristic analysis after correcting for center effects was used as well as mixed models to test the impact of covariates on CAP. The primary outcome was establishing CAP cut-offs for distinguishing steatosis grades.Results Data from 19/21 eligible papers were provided, comprising 3830/3968 (97%) of patients. Considering data overlap and exclusion criteria, 2735 patients were included in the final analysis (37% hepatitis B, 36% hepatitis C, 20% NAFLD/NASH, 7% other). Steatosis distribution was 51%/27%/16%/6% for S0/S1/S2/S3. CAP values in dB/m (95% CI) were influenced by several covariates with an estimated shift of 10 (4.5-17) for NAFLD/NASH patients, 10 (3.5-16) for diabetics and 4.4 (3.8-5.0) per BMI unit. Areas under the curves were 0.823 (0.809-0.837) and 0.865 (0.850-0.880) respectively. Optimal cut-offs were 248 (237-261) and 268 (257-284) for those above S0 and S1 respectively.Conclusions CAP provides a standardized non-invasive measure of hepatic steatosis. Prevalence, etiology, diabetes, and BMI deserve consideration when interpreting CAP. Longitudinal data are needed to demonstrate how CAP relates to clinical outcomes.Lay summary There is an increase in fatty liver for patients with chronic liver disease, linked to the epidemic of the obesity. Invasive liver biopsies are considered the best means of diagnosing fatty liver. The ultrasound based controlled attenuation parameter (CAP) can be used instead, but factors such as the underlying disease, BMI and diabetes must be taken into account. Registration: Prospero CRD42015027238.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2016.12.022

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statisctics and computing/Statistics and computing · doi:10.1007/978-0-387-21706-2 · Cited by 25,941
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Fitting Linear Mixed-Effects Models Using lme4Preprint
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,854
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
Bédossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,189
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2015) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,002

Show all 65 references

Sorted by citations

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Self-citation
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
Self-citation
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Self-citation
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M. R., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M. R., & Cortez‐Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 953
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss
Pouwels, S., Sakran, N., Graham, Y. N. H., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K. K., & Ramnarain, D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00980-1 · Cited by 912
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Stefan, N., Häring, H., & Cusi, K. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 874
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Eslam, M., Sarin, S. K., Wong, V. W., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M., Shiha, G. E.-S., Yilmaz, Y. N., Gani, R. A., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 851
Self-citation
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
Wong, V. W., Adams, L. A., de Lédinghen, V., Wong, G. L., & Sookoian, S. C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0014-9 · Cited by 617
Self-citation
Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
Ferraioli, G., Wong, V. W., Castéra, L., Berzigotti, A., Sporea, I., Dietrich, C. F., Choi, B. I., Wilson, S. R., Kudo, M., & Barr, R. G. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.07.008 · Cited by 574
Self-citation
Ultrasound-based techniques for the diagnosis of liver steatosis
Ferraioli, G., & Monteiro, L. B. S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i40.6053 · Cited by 511
Self-citation
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 522
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
Caussy, C., Alquiraish, M. H., Nguyen, P., Hernandez, C., Cepin, S., Fortney, L., Ajmera, V. H., Bettencourt, R., Collier, S., Hooker, J. C., et al. (2017) · Hepatology · doi:10.1002/hep.29639 · Cited by 378
Non-alcoholic fatty liver disease
Maurice, J. B., & Manousou, P. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-3-245 · Cited by 387
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 347
Self-citation
Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions
Kennedy, P., Wagner, M., Castéra, L., Hong, C. W., Johnson, C. L., Sirlin, C. B., & Taouli, B. A. (2018) · Radiology · doi:10.1148/radiol.2018170601 · Cited by 272
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
Petroff, D., Blank, V., Newsome, P. N., Shalimar, Voican, C. S., Thiele, M., de Lédinghen, V., Baumeler, S., Chan, W. K., Perlemuter, G., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30357-5 · Cited by 268
Self-citation
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD
Tamaki, N., Ajmera, V. H., & Loomba, R. S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00584-0 · Cited by 265
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
Zhou, J., Cai, J., She, Z., & Li, H. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i11.1307 · Cited by 248
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging
Wáng, Y. X. J., & Idée, J.-M. (2017) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2017.02.09 · Cited by 247
Noninvasive Diagnosis of NAFLD and NASH
Piazzolla, V., & Mangia, A. (2020) · Cells · doi:10.3390/cells9041005 · Cited by 237
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Sterling, R. K., Duarte‐Rojo, A., Patel, K., Asrani, S. K., Alsawas, M., Dranoff, J. A., Fiel, M. I., Murad, M. H., Leung, D. H., Levine, D., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000843 · Cited by 232
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
Tacke, F., Horn, P., Wong, V. W., Ratziu, V., Bugianesi, E., Francque, S., Zelber‐Sagi, S., Valenti, L. V. C., Roden, M., Schick, F., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06196-3 · Cited by 221
Self-citation
Imaging biomarkers of NAFLD, NASH, and fibrosis
Ajmera, V. H., & Loomba, R. S. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101167 · Cited by 214
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
Fan, J., Wei, L., & Zhuang, H. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12685 · Cited by 198
Self-citation
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 204
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Pu, K., Wang, Y., Bai, S., Wei, H., Zhou, Y., Fan, J., & Qiao, L. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0961-9 · Cited by 197
Self-citation
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Liu, S.-Y., Tsai, I., & Hsu, Y.-C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105170 · Cited by 186
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Moreno, C., Mueller, S., & Szabó, G. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.11.025 · Cited by 182
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
Abeysekera, K. W. M., Fernandes, G., Hammerton, G., Portal, A. J., Gordon, F. H., Heron, J., & Hickman, M. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30419-4 · Cited by 182
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
Tapper, E. B., & Loomba, R. S. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.10 · Cited by 180
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Eslam, M., Fan, J., Yu, M., Wong, V. W., Cua, I. H., Liu, C., Tanwandee, T., Gani, R. A., Seto, W., Alam, S., et al. (2025) · Hepatology International · doi:10.1007/s12072-024-10774-3 · Cited by 200
Self-citation
Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
Lee, Y., Cho, Y., Lee, B., Park, C., Lee, D. H., Soo, B., & Rhee, E. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0011 · Cited by 169
Serotonin signals through a gut-liver axis to regulate hepatic steatosis
Choi, W., Namkung, J., Hwang, I., Kim, H., Lim, A., Lee, H. W., Lee, H. W., Han, K., Park, S., Jeong, J.-S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07287-7 · Cited by 166
Self-citation
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 165
Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
Serra-Burriel, M., Graupera, I., Torán, P., Thiele, M., Roulot, D., Wai-Sun Wong, V., Neil Guha, I., Fabrellas, N., Arslanow, A., Expósito, C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.019 · Cited by 160
Self-citation
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease
Fujiwara, Y., Kuroda, H., Abe, T., Ishida, K., Oguri, T., Noguchi, S., Sugai, T., Kamiyama, N., & Takikawa, Y. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.06.017 · Cited by 160
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
Ferraioli, G., Berzigotti, A., Barr, R. G., Choi, B. I., Cui, X. W., Dong, Y., Gilja, O. H., Lee, J. Y., Lee, D. H., Moriyasu, F., et al. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.06.002 · Cited by 159
Self-citation
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Cao, Y.-T., Xiang, L.-L., Qi, F., Zhang, Y., Chen, Y., & Zhou, X. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101547 · Cited by 159
Noninvasive assessment of liver fibrosis in NAFLD
Sanyal, A. J., Castera, L., & Wong, V. W.-S. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.03.042 · Cited by 157
Self-citation
Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard
Ferraioli, G., Maiocchi, L., Raciti, M. V., Tinelli, C., Silvestri, A. D., Nichetti, M., Cata, P. D., Rondanelli, M., Chiovato, L., Calliada, F., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000081 · Cited by 157
Self-citation
Non-alcoholic Fatty Liver Disease: A Clinical Update
Pappachan, J. M., Babu, S. V., Krishnan, B., & Ravindran, N. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00013 · Cited by 166
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Mak, L.-Y., Hui, R. W.-H., Fung, J., Liu, F., Wong, D. K.-H., Cheung, K.-S., Yuen, M.-F., & Seto, W.-K. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.040 · Cited by 152
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation
Hamesch, K., Mandorfer, M., Pereira, V. M., Moeller, L. S., Pons, M., Dolman, G. E., Reichert, M., Schneider, C. V., Woditsch, V., Voss, J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.013 · Cited by 152
Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique
Bae, J. S., Lee, D. H., Lee, J. Y., Kim, H., Yu, S. J., Lee, J., Cho, E. J., Lee, Y. B., Han, J. K., & Choi, B. I. (2019) · European Radiology · doi:10.1007/s00330-019-06272-y · Cited by 151
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis
Tada, T., Iijima, H., Kobayashi, N., Yoshida, M., Nishimura, T., Kumada, T., Kondo, R., Yano, H., Kage, M., Nakano, C., et al. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.05.033 · Cited by 146
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Лазебник, Л. Б., Голованова, Е. В., Туркина, С. В., Raikhelson, K. L., Okovityy, S. V., Drapkina, O. M., Maev, I. V., Ai, M., Ройтберг, Г. Е., Khlynova, O. V., et al. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-185-1-4-52 · Cited by 162
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
Wong, V. W., Petta, S., Hiriart, J., Cammà, C., Wong, G. L., Marra, F., Vergniol, J., Chan, A. W. H., Tuttolomondo, A., Merrouche, W., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.005 · Cited by 140
Self-citation
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification
Ferraioli, G., Barr, R. G., Berzigotti, A., Sporea, I., Wong, V. W., Reiberger, T., Karlas, T., Thiele, M. S., Cardoso, A. C., Ayonrinde, O. T., et al. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.03.014 · Cited by 140
Self-citation
Application of transient elastography in nonalcoholic fatty liver disease
Zhang, X., Wong, G. L., & Wong, V. W. (2019) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2019.0001n · Cited by 138
Self-citation
Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis
Lee, D. H., Cho, E. J., Bae, J. S., Lee, J. Y., Yu, S. J., Kim, H., Lee, K. B., Han, J. K., & Choi, B. I. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.05.034 · Cited by 138
Breakthroughs in therapies for NASH and remaining challenges
Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132
Non-alcoholic fatty liver disease and the interface between primary and secondary care
Tsochatzis, E. A., & Newsome, P. N. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30077-3 · Cited by 130
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
Dedov, I. I., Shestakova, M. V., Mel'nichenko, G. A., Mazurina, N. V., Andreeva, E. N., Bondarenko, I. Z., Руслановна, Г. З., Dzgoeva, F. K., Елисеев, М. С., Ershova, E. V., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12714 · Cited by 163
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 124
Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B
Seto, W., Hui, R. W., Mak, L., Fung, J., Cheung, K. S., Liu, K. S. H., Wong, D. K.-H., Lai, C., & Yuen, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.044 · Cited by 126
Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
Tian, T., Zhang, J., Xie, W., Ni, Y., Fang, X., Liu, M., Peng, X., Wang, J., Dai, Y., & Zhou, Y. (2022) · Nutrients · doi:10.3390/nu14214505 · Cited by 129
Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study
Duncan, A., Goff, L. M., & Peters, B. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194199 · Cited by 122
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Kim, N. H., Seo, J. A., Kim, M. K., Lim, J. H., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0282 · Cited by 129
Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance
Ozturk, A., Grajo, J. R., Gee, M. S., Benjamin, A., Zubajlo, R. E., Thomenius, K. E., Anthony, B., Samir, A. E., & Dhyani, M. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.07.019 · Cited by 114
Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018
Zhang, X., Heredia, N. I., Balakrishnan, M., & Thrift, A. P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252164 · Cited by 113
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
Loomba, R. S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.028 · Cited by 112
Non-invasive testing and risk-stratification in patients with MASLD
Zoncapè, M., Liguori, A., & Tsochatzis, E. A. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.01.013 · Cited by 112
Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
Byrne, C. D., Patel, J., Scorletti, E., & Targher, G. (2018) · BMJ · doi:10.1136/bmj.k2734 · Cited by 110
Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography
Lai, L. L., Yusoff, W. N. I. W., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14577 · Cited by 106
Self-citation
Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard
Jeon, S. K., Lee, J. M., Joo, I., Yoon, J. H., Lee, D. H., Lee, J. Y., & Han, J. K. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.02.008 · Cited by 106
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey
Ciardullo, S., Monti, T., & Perseghin, G. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.048 · Cited by 108
Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Mauro, S. D., Scamporrino, A., Filippello, A., Pino, A. D., Scicali, R., Malaguarnera, R., Purrello, F., & Piro, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111905 · Cited by 104
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Duseja, A. K., Singh, S. P., De, A., Madan, K., Rao, P. N., Shukla, A., Choudhuri, G., Saigal, S., Shalimar, S., Arora, A., et al. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.014 · Cited by 107
Self-citation
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Huang, S., & Liu, C. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0422 · Cited by 108
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Roeb, E., Canbay, A. E., Tacke, F., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., Denzer, U. W., Geier, A., Hofmann, W. P., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2283 · Cited by 108
Self-citation
Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis
Lefebvre, T. L., Wartelle‐Bladou, C., Wong, P. Y. N., Sebastiani, G., Giard, J., Castel, H., Murphy-Lavallée, J., Olivié, D., Ilinca, A. P., Sylvestre, M., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06331-4 · Cited by 100
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
Schneider, C. V., Hamesch, K., Groß, A., Mandorfer, M., Moeller, L. S., Pereira, V. M., Pons, M., Kuca, P., Reichert, M., Benini, F., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.058 · Cited by 99
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
Pembroke, T., Deschênes, M., Lebouché, B., Benmassaoud, A., Sewitch, M. J., Ghali, P., Wong, P. Y. N., Halme, A. S., Vuille‐Lessard, É., Pexos, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.011 · Cited by 98
Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification
Thiele, M. S., Rausch, V., Fluhr, G., Kjærgaard, M., Piecha, F., Mueller, J. H., Straub, B. K., Lupșor‐Platon, M., de Lédinghen, V., Seitz, H. K., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.029 · Cited by 97
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population
Petta, S., Marco, V. D., Pipitone, R. M., Grimaudo, S., Buscemi, C., Craxı̀, A., & Buscemi, S. (2018) · Liver International · doi:10.1111/liv.13743 · Cited by 97
Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort
Burgio, M. D., Ronot, M., Reizine, É., Rautou, P., Castéra, L., Paradis, V., Garteiser, P., BEERS, B. E. V., & Vilgrain, V. (2019) · European Radiology · doi:10.1007/s00330-019-06480-6 · Cited by 97
Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy
de Lédinghen, V., Hiriart, J., Vergniol, J., Merrouche, W., Bédossa, P., & Paradis, V. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4638-3 · Cited by 95
Self-citation
Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography
Palumbo, C. S., Restellini, S., Chao, C., Aruljothy, A., Lemieux, C., Wild, G., Afif, W., Lakatos, P. L., Bitton, A., Cocciolillo, S., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy200 · Cited by 89
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Lombardi, R., Airaghi, L., Targher, G., Serviddio, G., Maffi, G., Mantovani, A., Maffeis, C., Colecchia, A., Villani, R., Rinaldi, L., et al. (2019) · Liver International · doi:10.1111/liv.14274 · Cited by 87
Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
Liu, K., Wong, V. W., Lau, K., Liu, S. D., Tse, Y., Yip, T. C., Kwok, R., Chan, A. Y.-W., Chan, H. L., & Wong, G. L. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.389 · Cited by 84
Self-citation
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
Lee, H. W., Wong, G. L., Kwok, R., Choi, K. C., Chan, C. K., Shu, S. S., Leung, J. K., Chim, A. M., Luk, A. O. Y., Ronald, C. W., et al. (2020) · Hepatology · doi:10.1002/hep.31142 · Cited by 80
Self-citation
Advances in liver US, CT, and MRI: moving toward the future
Vernuccio, F., Cannella, R., Bartolotta, T. V., Galia, M., Tang, A., & Brancatelli, G. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00250-0 · Cited by 79
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
Fan, J., Xu, X., Yang, R.-X., Nan, Y., Wei, L., Jia, J., Zhuang, H., Shi, J., Li, X., Cm, S., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00311 · Cited by 92
Self-citation
Characterization of the immune cell landscape of patients with NAFLD
Diedrich, T., Kummer, S., Galante, A., Drolz, A., Schlicker, V., Lohse, A. W., Kluwe, J., Eberhard, J. M., & Wiesch, J. S. Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230307 · Cited by 83
Role of Ultrasound Methods for the Assessment of NAFLD
Petzold, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154581 · Cited by 78
Definition of healthy ranges for alanine aminotransferase levels: a 2021 update
Valenti, L., Pelusi, S., Bianco, C., Ceriotti, F., Berzuini, A., Iogna Prat, L., Trotti, R., Malvestiti, F., D’Ambrosio, R., Lampertico, P., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1794 · Cited by 77
Ultrasonic Adaptive Sound Speed Estimation for the Diagnosis and Quantification of Hepatic Steatosis: A Pilot Study
Burgio, M. D., Imbault, M., Ronot, M., Faccinetto, A., BEERS, B. E. V., Rautou, P., Castéra, L., Gennisson, J., Tanter, M., & Vilgrain, V. (2018) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/a-0660-9465 · Cited by 77
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors
Rodríguez-Duque, J. C., Calleja, J. L., Iruzubieta, P., Hernández‐Conde, M., Rivas, C., Vera, M. I., García, M. J., Pascual, M., Castro, B., García-Blanco, A., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.039 · Cited by 75
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
Noureddin, M., Wong, M. M., Todo, T., Lu, S. C.-L., Sanyal, A. J., & Mena, E. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i11.1269 · Cited by 71
Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy
Perazzo, H., Cardoso, S. W., Yanavich, C., Nunes, E. P., Morata, M., Gorni, N., da Silva, P. S., Cardoso, C. S. D. A., de Almeida, C. F., Luz, P. M., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25201 · Cited by 69
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
Yoneda, M., Imajo, K., Takahashi, H., Ogawa, Y., Eguchi, Y., Sumida, Y., Yoneda, M., Kawanaka, M., Saito, S., Tokushige, K., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1414-2 · Cited by 69
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Campos-Murguía, A., Ruiz‐Margáin, A., González-Regueiro, J. A., & Macías‐Rodríguez, R. U. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i39.5919 · Cited by 75
Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Qu, Y., Song, Y., Chen, C., Fu, Q., Shi, J., Xu, Y., Xie, Q., Yang, Y., Zhou, Y., Li, L.-P., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000323 · Cited by 69
Self-citation
Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study
Jang, J. K., Lee, E. S., Seo, J. W., Kim, Y. R., Kim, S. Y., Cho, Y. Y., & Lee, D. H. (2022) · Radiology · doi:10.1148/radiol.220220 · Cited by 69
Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
Cho, E. J., Jung, G., Kwak, M., Yang, J. I., Yim, J.-Y., Yu, S.-J., & Chung, G. E. (2021) · Diagnostics · doi:10.3390/diagnostics11122233 · Cited by 67
Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis
Decharatanachart, P., Chaiteerakij, R., Tiyarattanachai, T., & Treeprasertsuk, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211062807 · Cited by 67
Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial
Charatcharoenwitthaya, P., Kuljiratitikal, K., Aksornchanya, O., Chaiyasoot, K., Bandidniyamanon, W., & Charatcharoenwitthaya, N. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000316 · Cited by 72
Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut‐Offs to Use?
Șirli, R., & Sporea, I. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6662760 · Cited by 65
Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease
Kwan, S., Jiao, J., Joon, A. Y., Wei, P., Petty, L. E., Below, J. E., Daniel, C. R., Wu, X., Zhang, J., Jenq, R. R., et al. (2021) · Hepatology · doi:10.1002/hep.32197 · Cited by 64

Authors: Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., Ferraioli, G., Chan, W.-K., Wong, V. W.-S., Myers, R. P., Chayama, K., Friedrich-Rust, M., Beaugrand, M., Shen, F., Hiriart, J.-B., Sarin, S. K., Badea, R., Jung, K. S., Marcellin, P., Filice, C., Mahadeva, S., Wong, G. L.-H., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V., & Wiegand, J.
Affiliations: University Hospital Leipzig (DE)
IFB Adiposity Diseases (DE)
Echosens (France) (FR)
Shanghai Jiao Tong University (CN)
Institute of Liver and Biliary Sciences (IN)
Yonsei University (KR)
Inserm (FR)
University of Pavia (IT)
University of Malaya (MY)
Chinese University of Hong Kong (HK)
University of Calgary (CA)
Hiroshima University Hospital (JP)
Hôpital Jean-Verdier (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Iuliu Hațieganu University of Medicine and Pharmacy (RO)
University Hospital Frankfurt (DE)
Corresponding author: Wiegand, Johannes
ORCID: Karlas, Thomas
Petroff, David
Sasso, Magali
Fan, Jian-Gao
Kumar, Manoj
Han, Kwang-Hyub
Cardoso, Ana C.
Ferraioli, Giovanna
Chan, Wah-Kheong
Wong, Vincent Wai-Sun
Chayama, Kazuaki
Shen, Feng
Hiriart, Jean-Baptiste
Sarin, Shiv K.
Badea, Radu
Marcellin, Patrick
Mahadeva, Sanjiv
Wong, Grace Lai-Hung
Crotty, Pam
Bojunga, Joerg
Wiegand, Johannes
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2017-05
Volume: 66
Issue: 5
Pages: 1022-1030
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2016.12.022
OpenAlex: W2564467149
Cited by: 1,275
References: 65
Citations by year: 2026: 164 · 2025: 185 · 2024: 180 · 2023: 139 · 2022: 161 · 2021: 150 · 2020: 117 · 2019: 77 · 2018: 67 · 2017: 31
FWCI: 7.94
Type: journal article
Language: en
Open access: green
www.sciencedirect.com
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Ultrasound in Clinical Applications
Keywords: controlled attenuation parameter, hepatic steatosis, vibration-controlled transient elastography, FibroScan, chronic liver disease, diabetes mellitus, body mass index, liver ultrasound, receiver operating characteristic
MeSH terms: Adult, Fatty Liver, Female, Humans, Male, Middle Aged, ROC Curve, Ultrasonography, Meta-Analysis as Topic, Body Mass Index, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks